Insulin/Glucose-Responsive Cells Derived from Induced Pluripotent Stem Cells: Disease Modeling and Treatment of Diabetes
Type 2 diabetes, characterized by dysfunction of pancreatic β-cells and insulin resistance in peripheral organs, accounts for more than 90% of all diabetes. Despite current developments of new drugs and strategies to prevent/treat diabetes, there is no ideal therapy targeting all aspects of the dise...
Main Authors: | Sevda Gheibi, Tania Singh, Joao Paulo M. C. M. da Cunha, Malin Fex, Hindrik Mulder |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-11-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/9/11/2465 |
Similar Items
-
Building Implantable Human Liver Tissue from Pluripotent Stem Cells
by: David Hay
Published: (2023-03-01) -
Immune cells and RBCs derived from human induced pluripotent stem cells: method, progress, prospective challenges
by: Jin-he Jiang, et al.
Published: (2024-01-01) -
Standards for Deriving Nonhuman Primate-Induced Pluripotent Stem Cells, Neural Stem Cells and Dopaminergic Lineage
by: Guang Yang, et al.
Published: (2018-09-01) -
Insulin regulates human pancreatic endocrine cell differentiation in vitro
by: Perla Cota, et al.
Published: (2024-01-01) -
Alzheimer’s in a dish – induced pluripotent stem cell-based disease modeling
by: Sherida de Leeuw, et al.
Published: (2019-07-01)